logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5569.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5569.produseast1
Showing 1 - 3 of 3 Items
Showing 1 - 3 of 3 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Longer-term virologic outcomes on tenofovir-lamivudine-dolutegravir in second-line ART

Van Heerden JK, Zhao Y, Keene CM, Griesel R, Omar Z,  et al.
2025-04-30 • South African Journal of HIV Medicine
2025-04-30 • South African Journal of HIV Medicine

BACKGROUND

Dol...

Journal Article
|
Research

Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial

Rangaka MX, Wilkinson RJ, Boulle AM, Glynn JR, Fielding K,  et al.
2014-05-14 • Lancet
2014-05-14 • Lancet
Antiretroviral therapy reduces the risk of tuberculosis, but tuberculosis is more common in people with HIV than in people without HIV. We aimed to assess the effect of isoniazid prevent...
Journal Article
|
Research

Effect of Antiretroviral Therapy on the Diagnostic Accuracy of Symptom Screening for Intensified Tuberculosis Case Finding in a South African HIV clinic

Rangaka MX, Wilkinson RJ, Glynn JR, Boulle AM, van Cutsem G,  et al.
2012-09-05 • Clinical Infectious Diseases
2012-09-05 • Clinical Infectious Diseases
Current symptom screening algorithms for intensified tuberculosis case finding or prior to isoniazid preventive therapy (IPT) in patients infected with human immunodeficiency virus (HIV)...